Jade Biosciences
(NASDAQ) JBIO
Jade Biosciences Financials at a Glance
Market Cap
$690.43M
Revenue (TTM)
$0.00
Net Income (TTM)
$127.41M
EPS (TTM)
$-5.45
P/E Ratio
-2.57
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$13.96
Volume
2,605,469
Open
$14.10
Price
$13.96
Volume
2,605,469
Open
$14.10
Previous Close
$14.00
Daily Range
$13.70 - $14.18
52-Week Range
$6.57 - $100.10
Dividend
$0.00
Beta (Volatility)
0.09 (Low)
Price
$13.96
Volume
2,605,469
Open
$14.10
Previous Close
$14.00
Daily Range
$13.70 - $14.18
52-Week Range
$6.57 - $100.10
JBIO News
JBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jade Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
55
CEO
Tom Frohlich, MBA
Website
www.jadebiosciences.comHeadquarters
Waltham, MA 02453, US
JBIO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-45%
Return on Capital
-28%
Return on Assets
-36%
Earnings Yield
-38.91%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$690.43M
Shares Outstanding
49.32M
Volume
2.61M
Short Interest
0.00%
Avg. Volume
324.93K
Financials (TTM)
Gross Profit
$26.00K
Operating Income
$113.54M
EBITDA
$113.54M
Operating Cash Flow
$94.69M
Capital Expenditure
$196.00K
Free Cash Flow
$94.89M
Cash & ST Invst.
$336.16M
Total Debt
$724.00K
Jade Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$9.00K
-12.5%
Gross Margin
0.00%
N/A
Market Cap
$690.43M
N/A
Market Cap/Employee
$13.81M
N/A
Employees
50
N/A
Net Income
$67.58M
-1144.6%
EBITDA
$34.90M
-550.3%
Quarterly Fundamentals
Net Cash
$335.43M
+328.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$724.00K
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-36.43%
N/A
Return on Invested Capital
-28.07%
N/A
Free Cash Flow
$33.65M
-190.2%
Operating Cash Flow
$33.65M
-190.2%